Author response for "Improved Glycemic Variability and Time in Range with Dapagliflozin versus Gliclazide Modified Release among Adults with Type 2 Diabetes Evaluated by Continuous Glucose Monitoring: A 12‐week Randomized Controlled Trial"
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
